Retinal Biologics Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Retinal Biologics Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

FMI’s recently published report titled ‘Retinal Biologics Market: Global Industry Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028' offers a comprehensive assessment of the key dynamics pertaining to the retinal biologics market. The report presents growth prospects for the retinal biologics market, which have been obtained with maximum precision through detailed research on the historic as well as current growth parameters.

The report discusses the prominent factors that are likely to have a significant impact on the development of the retinal biologics market during the forecast period. This information will prove to be key for market players to modify their manufacturing and marketing strategies and envisage maximum growth in the retinal biologics market in the coming years.

Chapter 1 – Executive Summary

The report commences with an executive summary, which comprises a summary of the key findings and statistics pertaining to the retinal biologics market. This section also provides market value (US$ Million) estimates for the leading segments of the retinal biologics market.

Chapter 2 – Market Overview

Readers can find a detailed taxonomy and definitions in this chapter to help them better understand the basic information about the retinal biologics market dynamics, pricing analysis, list of key manufacturers and key regulation policies included in the succeeding sections of the report.

Chapter 3 – Global Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028 by Drug Class

On the basis of drug class, the retinal biologics market has been segmented into VEGF-A antagonist and TNF-α inhibitor. In this chapter, readers can find information about the key trends and developments observed in the retinal biologics market. The section also comprises a market attractiveness analysis of the segments on the basis of drug class.

Chapter 4 – Global Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028 by Indication

Based on indication, the retinal biologics market has been segmented into macular degeneration, diabetic retinopathy, diabetic macular edema, uveitis and others. In this section, readers can find information about device usage, key trends and technological developments in the retinal biologics market along with a market attractiveness analysis of the key segments based on indication.

Chapter 5 – Global Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028 by Distribution Channel

By distributional channel, the retinal biologics market has been segmented into institutional sales, which has further been sub-segmented into specialty clinics and hospitals and retail sales, which has further been sub-segmented into retail pharmacies and mail order pharmacies. In this chapter, readers can find information about the key trends and developments identified in the retinal biologics market and a market attractiveness analysis of the key segments based on distributional channel.

Chapter 6 – Global Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028 by Region

This chapter explains how the retinal biologics market is expected to grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

Chapter 7 – North America Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

This chapter includes a detailed analysis of the growth of the retinal biologics market, along with a country-wise assessment for various countries in North America, including the U.S. and Canada. Readers can also find information on regional trends, macro-economic factors and market growth on the basis of drug class, indication, distributional channel and country for the retinal biologics market in North America.

Chapter 8 – Latin America Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

Readers can find detailed information about pricing analysis and regional trends impacting the growth of the Latin American retinal biologics market. This chapter also discusses growth prospects for the retinal biologics market in leading LATAM countries, such as Brazil, Mexico and the Rest of the Latin America.

Chapter 9 – Western Europe Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

Readers can find detailed information about the important growth parameters in the retinal biologics market in several European countries, such as Germany, the U.K., France, Italy, Spain and the rest of Western Europe.

Chapter 10 – Eastern Europe Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

Readers can find detailed information about the important growth parameters in the retinal biologics market for several European countries, such as the Russia, Poland and rest of Eastern Europe.

Chapter 11 – APEJ Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

Readers can find thorough information about the various parameters expected to impact the APEC retinal biologics market during the forecast period 2018 – 2028. China, India, Australia and New Zealand, ASEAN, rest of APAC are the leading countries/regions in APEJ and hence, the prime subject of assessment in this chapter.

Chapter 12 – Japan Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

Readers can find information on the important factors expected to make a significant impact on the growth of the retinal biologics market in Japan during the forecast period 2018 – 2028. This chapter provides an overview of the drivers, restraints and trends prevailing in the Japan retinal biologics market.

Chapter 13 – MEA Retinal Biologics Market Analysis 2013 – 2017 & Opportunity Assessment 2018 – 2028

Readers can find detailed information on how the retinal biologics market is expected to grow in major countries/regions of the MEA region, such as GCC Countries, South Africa, and the Rest of MEA during the period 2018 – 2028.

Chapter 14 – Competition Landscape, Company Share, and Company Profiles

In this chapter, readers can find a comprehensive list of all leading stakeholders in the retinal biologics market and detailed information about each company, including company overview, offered products, SWOT analysis, key strategy and recent company developments. The market players featured in the report include Spark Therapeutics, Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc., AbbVie Inc., Johnson & Johnson Services, Inc. and Amgen Inc.

Chapter 15 – Assumptions and Acronyms

This chapter of the retinal biologics market report includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 16 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the retinal biologics market.


Executive Summary
Market Overview
Market Analysis
FMI Analysis and Recommendations
Wheel of Fortune
Market Introduction
Market Taxonomy
Market Definition
Global Economic Outlook
Gross Domestic Indication Type by Region & Country, 2006 – 2021
Global Healthcare Market Indicators
Market Opportunity Analysis
Macro-Economic Factors
Opportunity Analysis
Market Dynamics
Drivers
Supply Side Drivers
Demand Side Drivers
Restraints
Trends
Key Inclusion
Key Regulations
Reimbursement Scenario
Pricing Analysis
North America Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
U.S.
Canada
Market Size (US$ Mn) Forecast By Country, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-An antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) and Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Country
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Latin America Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Regional Market Trends
Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
Brazil
Mexico
Argentina
Rest of Latin America
Market Size (US$ Mn) Forecast By Country, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) and Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Country
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Western Europe Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
Germany
U.K
France
Italy
Spain
Rest of Western Europe
Market Size (US$ Mn) Forecast By Country, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) and Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Country
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Eastern Europe Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
Russia
Poland
Rest of Eastern Europe
Market Size (US$ Mn) Forecast By Country, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) and Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Country
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Asia Pacific Excluding Japan Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
China
India
Australia and New Zealand
ASEAN
Rest of APEJ
Market Size (US$ Mn) Forecast By Country, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) and Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Country
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Japan Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) and Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Middle East and Africa Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Introduction
Historical Market Size (US$ Mn) Analysis by Country, 2013-2017
GCC Countries
South Africa
Rest of Middle East and Africa
Market Size (US$ Mn) Forecast By Country, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Historical Market Size (US$ Mn) and Trend Analysis by Indication, 2013-2017
Macular degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) and Forecast By Indication, 2018-2028
Historical Market Size (US$ Mn) Trend Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis
By Country
By Drug Class
By Indication
By Distributional Channel
Drivers and Restraints: Impact Analysis
Key Market Participants – Intensity Mapping
Forecast Factors: Relevance and Impact
Forecast Assumptions
Competition Analysis
Competition Dashboard
Competitors Deep Dive
Spark Therapeutics Inc.
Overview
Key Financials
SWOT Analysis
Key Developments
Key Strategy
Hoffmann-La Roche Ltd
Overview
Key Financials
SWOT Analysis
Key Developments
Key Strategy
Regeneron Pharmaceuticals, Inc.
Overview
Key Financials
SWOT Analysis
Key Developments
Key Strategy
AbbVie Inc
Overview
Key Financials
SWOT Analysis
Key Developments
Key Strategy
Johnson & Johnson Services, Inc
Overview
Key Financials
SWOT Analysis
Key Developments
Key Strategy
Amgen Inc.
Overview
Key Financials
SWOT Analysis
Key Developments
Key Strategy
Global Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028 by Region
Introduction / Key Findings
Historical Market Size (US$ Mn) Analysis by Region
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
Middle East and Africa
Market Size (US$ Mn) Forecast By Region
Market Attractiveness Analysis by Region
Global Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028, By Drug Class
Introduction/Key Finding
Historical Market Size (US$ Mn) Analysis by Drug Class, 2013-2017
VEGF-A antagonist
TNF-α inhibitor
Market Size (US$ Mn) Forecast By Drug Class, 2018-2028
Market Attractiveness Analysis by Drug Class
Global Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028, By Indication
Introduction/Key Finding
Historical Market Size (US$ Mn) Analysis by Indication, 2013-2017
Macular degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Uveitis
Others
Market Size (US$ Mn) Forecast By Indication, 2018-2028
Market Attractiveness Analysis by Indication
Global Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028, By Distributional Channel
Introduction/Key Finding
Historical Market Size (US$ Mn) Analysis by Distributional Channel, 2013-2017
Institutional Sales
Specialty Clinics
Hospitals
Retail Sales
Retail Pharmacies
Mail Order Pharmacies
Market Size (US$ Mn) Forecast By Distributional Channel, 2018-2028
Market Attractiveness Analysis by Distributional Channel
Global Retinal Biologics Market Analysis 2013–2017 and Forecast 2018–2028
Global Market Value Analysis (US$ Mn)
Absolute $ Opportunity
Assumptions and Acronyms Used
Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook